Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Ventricular Tachycardia After Cardioversion
Author(s): Eiad Habib , Mahmoud Abdelnabi , Ramzi Ibrahim , et al Added: 5 months ago

Electrophysiology & Arrhythmia

Heart Failure
RFCA in Infant AiCM
Author(s): Xuan Li , Wenjuan Shu , Miao Hou , et al Added: 2 weeks ago

Imaging & Diagnostics

CV Disease in Special Populations
Defining AF Cardiomyopathy
Author(s): Nikhil Ahluwalia , Shohreh Honarbakhsh , Ross Hunter , et al Added: 2 months ago

Electrophysiology & Arrhythmia

Heart Failure
Ablation Methods for Ventricular Tachycardia Ablation. Part 2
Author(s): Maria Niespialowska-Steuden , John Silberbauer , Jaffar Al-Sheikhli , et al Added: 1 week ago

Electrophysiology & Arrhythmia
Ablation Methods for Ventricular Tachycardia Ablation. Part 1
Author(s): Maria Niespialowska-Steuden , John Silberbauer , Jaffar Al-Sheikhli , et al Added: 1 week ago

Electrophysiology & Arrhythmia
Dynamic Voltage Mapping of Ventricular Tachycardia Substrate
Author(s): Mark T Mills , Peter Calvert , Justin Chiong , et al Added: 1 year ago

Electrophysiology & Arrhythmia
Functional Substrate Mapping
Author(s): Jaffar Al-Sheikhli , Patrick Tran , Rafaella Siang , et al Added: 1 year ago

Electrophysiology & Arrhythmia
Cardioneuroablation for Reflex Syncope
Author(s): Piotr Kulakowski , Roman Piotrowski Added: 11 months ago

Electrophysiology & Arrhythmia
POTS-associated Conditions and Management Strategies
Author(s): Alexis Cutchins , Svetlana Blitshteyn , Rebecca Steinberg Added: 2 years ago
Postural Orthostatic Tachycardia Syndrome (POTS) is a heterogenous disorder that presents with positional tachycardia, amongst many other symptoms. Evidence for treatment options remains limited, and there are a multitude of associated conditions with overlapping symptoms which can make the diagnosis and management of POTS a difficult experience for providers and patients alike.This broadcast… View more

Electrophysiology & Arrhythmia

COVID-19
Etripamil in Paroxysmal Supraventricular Tachycardia Care: Highlights from Recent AHA Analyses
Author(s): Narendra Singh Added: 5 months ago
AHA 2025 — In this interview, Dr Narendra Singh (NSC Cardiology, Atlanta, US) reviews the latest AHA data on etripamil, an investigational intranasal, nondihydropyridine calcium channel blocker for the rapid self-termination of paroxysmal supraventricular tachycardia (PSVT).Dr Singh discusses the burden of PSVT, key findings from randomized and open-label studies, conversion rates with single and… View more

Electrophysiology & Arrhythmia